NCT00033241View on ClinicalTrials.gov

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 23, 2001

Primary Completion Date

April 22, 2004

Study Completion Date

April 22, 2004

Conditions
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

erlotinib hydrochloride

DRUG

gemcitabine hydrochloride

Trial Locations (2)

85724

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

78229-3271

Cancer Therapy and Research Center, San Antonio

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OSI Pharmaceuticals

INDUSTRY